Stem Cell Versus Platelet-rich Plasma for Knee Osteoarthritis: A Systematic Review
Open Access
- 4 January 2023
- journal article
- review article
- Published by Scientific Foundation Spiroski (publications) in Open Access Macedonian Journal of Medical Sciences
- Vol. 11 (F) , 163-170
Abstract
AIM: The objective is to compare the outcomes of intra-articular injection of mesenchymal stem cells (MSCs) to platelet-rich plasma (PRP) as a treatment modality for knee osteoarthritis (OA). METHODS: Systematic review was conducted based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses and PICO criteria for the past 10 years of publications. Keywords used to search with Boolean operator: “knee OA” AND “MSCs” AND“PRP” AND “outcome.” All selected articles were assessed for their quality based on strengthening the Reporting of Observational Studies in Epidemiology checklist. RESULTS: We selected five articles of prospective cohort studies, which involved 54 patients whom received combination therapies of MSCs+PRP, 206 patients received MSCs only treatment and 86 patients received PRP only treatment. It was shown that MSCs had superior outcomes compared to PRP treatment in terms of VAS and KOOS, where combinations of MSCs and PRP treatment had no significant difference compared to the MSCs treatment alone. Nonetheless, each treatment showed a significant improvement of KOOS, VAS, WOMAC, IKDC, knee, and function knee scores from their baselines. CONCLUSION: Intra-articular injections are effective and safe for the management of knee OA. MSCs treatment has superior effect on the treatment outcomes compared to PRP treatment. Combination of both treatments is comparable to MSCs treatment alone.Keywords
This publication has 17 references indexed in Scilit:
- 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and KneeArthritis & Rheumatology, 2020
- Intra-articular injection of culture-expanded mesenchymal stem cells with or without addition of platelet-rich plasma is effective in decreasing pain and symptoms in knee osteoarthritis: a controlled, double-blind clinical trialKnee Surgery, Sports Traumatology, Arthroscopy, 2019
- New biotechnologies for musculoskeletal injuriesThe Surgeon, 2019
- Intra-articular injections of expanded mesenchymal stem cells with and without addition of platelet-rich plasma are safe and effective for knee osteoarthritisKnee Surgery, Sports Traumatology, Arthroscopy, 2018
- Platelet-Rich Plasma for the Management of Hip and Knee OsteoarthritisCurrent Rheumatology Reports, 2017
- Comparative Outcomes of Open‐Wedge High Tibial Osteotomy With Platelet‐Rich Plasma Alone or in Combination With Mesenchymal Stem Cell Treatment: A Prospective StudyArthroscopy, 2014
- Epidemiology of OsteoarthritisClinics in Geriatric Medicine, 2010
- Comparison of effect of BMP-2, -4, and -6 on in vitro cartilage formation of human adult stem cells from bone marrow stromaCell and tissue research, 2005
- Stem cell therapy in a caprine model of osteoarthritisArthritis & Rheumatism, 2003
- Treatment of Deep Cartilage Defects in the Knee with Autologous Chondrocyte TransplantationNew England Journal of Medicine, 1994